Addex amends at-the-market offering agreement with H.C. Wainwright

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Addex amends at-the-market offering agreement with H.C. Wainwright

Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.

December 11, 2025 1:00 AM EST

Ad Hoc Announcement Pursuant to Art. 53 LR

Geneva, Switzerland, December 11, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it has amended its At The Market Offering Agreement (the ATM Agreement) with H.C. Wainwright & Co., LLC (H.C. Wainwright & Co.) initially entered into on January 30, 2024. The at-the-market offering program enables Addex to offer and sell, from time to time at its sole... More